These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Hepatic and renal toxicity to fluindione (Previscan)]. Cadranel JF; Demontis R; Seddik M; Ramdani S; Belloula D; Biour M Gastroenterol Clin Biol; 2008 Oct; 32(10):816-8. PubMed ID: 18818035 [No Abstract] [Full Text] [Related]
5. [Asymptomatic acute cytolytic hepatitis due to fluindione and associated with resistance to treatment: a case report and review of the literature]. Penot JP; Fontenelle P; Dorleac D Arch Mal Coeur Vaiss; 1998 Feb; 91(2):267-70. PubMed ID: 9749256 [TBL] [Abstract][Full Text] [Related]
6. [Drug hypersensitive syndrome caused by fluindione]. Sparsa A; Bédane C; Benazahary H; De Vencay P; Gauthier ML; Le Brun V; Boulinguez S; Loustaud-Ratti V; Soria P; Vidal E; Bonnetblanc JM Ann Dermatol Venereol; 2001 Oct; 128(10 Pt 1):1014-8. PubMed ID: 11907960 [TBL] [Abstract][Full Text] [Related]
7. [Acute interstitial nephritis of fluindione: about three cases]. Beauchamp C; Enache I; Haskour A; Martin L Nephrol Ther; 2008 Oct; 4(5):339-46. PubMed ID: 18417438 [TBL] [Abstract][Full Text] [Related]
8. [Potentiation of the anticoagulant effect of fluindione by propafenone]. Welsch M; Heitz C; Stephan D; Imbs JL Therapie; 1991; 46(3):254-5. PubMed ID: 1792662 [No Abstract] [Full Text] [Related]
9. [The interaction of oxaceprol and fluindione]. Bannwarth B; Tréchot P; Mathieu J; Froment J; Netter P Therapie; 1990; 45(2):162-3. PubMed ID: 2353333 [No Abstract] [Full Text] [Related]
10. [Drug interaction implicating miconazole in gel form and fluindione]. Ponge T; Rapp MJ; Fruneau P; Ponge A; Wassen-Hove L; Larousse C; Cottin S Therapie; 1987; 42(4):412-3. PubMed ID: 3686478 [No Abstract] [Full Text] [Related]